SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Generic Entry and the Pricing of Pharmaceuticals
0 references·16 citing·46 second hop
Generic Entry and the Pricing of Pharmaceuticals (1997)Generic Entry and the Pricing of Pharmace…Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States (2014)Measuring performance in off-…Higher US Branded Drug Prices And Spending Compared To Other Countries May Stem Partly From Quick Uptake Of New Drugs (2013)Higher US Branded Drug Prices…A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries (2011)A win-win solution?: A critic…Consumer learning and heterogeneity: Dynamics of demand for prescription drugs after patent expiration (2010)Consumer learning and heterog…Marketing of the Life Sciences: A New Framework and Research Agenda for a Nascent Field (2009)Marketing of the Life Science…Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation? (2008)Regulation and pricing of pha…International Prices And Availability Of Pharmaceuticals In 2005 (2008)International Prices And Avai…Generic entry, price competition, and market segmentation in the prescription drug market (2007)Generic entry, price competit…A Generic Solution? (2007)A Generic Solution?Reference pricing of pharmaceuticals (2006)Reference pricing of pharmace…Generic Competition in the US Pharmaceutical Industry (2006)Generic Competition in the US…Incumbent pricing responses to entry (2005)Incumbent pricing responses t…Parallel imports and the pricing of pharmaceutical products: evidence from the European Union (2004)Parallel imports and the pric…The effect of generic competition on the price of brand-name drugs (2003)The effect of generic competi…Pharmaceutical Pricing in a Regulated Market (2003)Pharmaceutical Pricing in a R…Review of the literature on reference pricing (2000)Review of the literature on r…Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Generic Entry and the Pricing of Pharmaceuticals (1997)Parallel Imports and Price Controls (2006)THE WELFARE IMPACT OF PARALLEL IMPORTS: A STRUCTURAL APPROACH APPLIED TO THE GERMAN MARKET FOR ORAL ANTI‐DIABETICS (2014)Patents and the Global Diffusion of New Drugs (2015)Prices And Availability Of Pharmaceuticals: Evidence From Nine Countries (2003)Pharmaceutical Price Controls and Entry Strategies (2007)Pharmaceutical pricing policies in a global market (2008)Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement (2013)Random group effects and the precision of regression estimates (1986)The Importance of the Physician in the Generic versus Trade-Name Prescription Decision (1998)Generic Drug Industry Dynamics (2005)The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms (2010)Physician Agency and Adoption of Generic Pharmaceuticals (2012)Funding Health Care: Options for Europe (2002)Policy objective of generic medicines from the investment perspective: The case of clopidogrel (2017)Expenditure on retail pharmaceuticals per capita, 2016 (2018)Manufacturing Process Innovation in the Pharmaceutical Industry (2021)What do we know about entry? (1995)Balancing Innovation and Access: Patent Challenges Tip the Scales (2009)Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry (2016)A Contribution to the Theory of Taxation (1927)Household catastrophic health expenditure: a multicountry analysis (2003)Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? (2014)Innovative Approaches to Increase Access to Medicines in Developing Countries (2017)Payers’ experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia (2017)Self-efficacy mechanism in human agency. (1982)A Conceptual Model of Service Quality and Its Implications for Future Research (1985)Evolving to a New Dominant Logic for Marketing (2003)Drivers of Sales Performance: A Contemporary Meta-Analysis (2010)Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development (2013)International new ventures: rapid internationalization across different industry contexts (2014)A New Product Growth Model for Consumer Durables (1976)Econometric policy evaluation: A critique (1976)Automobile Prices in Market Equilibrium (1995)A DYNAMIC OLIGOPOLY STRUCTURAL MODEL FOR THE PRESCRIPTION DRUG MARKET AFTER PATENT EXPIRATION* (2010)Industrial Market Structure and Economic Performance. (1971)Industrial market structure and economic performance (1990)Encouraging the use of generic medicines: implications for transition economies. (2002)Sustaining Generic Medicines Markets in Europe (2006)Estimating the Effect of Training Programs on Earnings (1978)Evaluating the Effect of Teachers’ Group Performance Incentives on Pupil Achievement (2002)Effects of Reference Pricing in Pharmaceutical Markets (2010)Does the Market Share of Generic Medicines Influence the Price Level? (2011)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2004Parallel imports and the pricing of pharmaceutical products: evidence from the European Union205 cited
  • 2000Review of the literature on reference pricing203 cited
  • 2010Consumer learning and heterogeneity: Dynamics of demand for prescription drugs after patent expiration190 cited
  • 2008International Prices And Availability Of Pharmaceuticals In 2005170 cited
  • 2014Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States168 cited
  • 2007Generic entry, price competition, and market segmentation in the prescription drug market161 cited
  • 2009Marketing of the Life Sciences: A New Framework and Research Agenda for a Nascent Field159 cited
  • 2008Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation?153 cited
  • 2006Generic Competition in the US Pharmaceutical Industry145 cited
  • 2011A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries138 cited
  • 2007A Generic Solution?136 cited
  • 2006Reference pricing of pharmaceuticals124 cited
  • 2013Higher US Branded Drug Prices And Spending Compared To Other Countries May Stem Partly From Quick Uptake Of New Drugs113 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2005
Incumbent pricing responses to entry
108 cited
  • 2003Pharmaceutical Pricing in a Regulated Market99 cited
  • 2003The effect of generic competition on the price of brand-name drugs97 cited